In solid-organ transplant recipients (OTRs) diagnosed with cancer post-transplant, treatment with sirolimus reduces the risk of developing a subsequent skin cancer, US investigators report in JAMA ...

To determine whether sirolimus (SIR) and cyclosporine (CSP) combined with post-transplantation cyclophosphamide (PTCy), after nonmyeloablative or reduced-intensity conditioning unrelated donor ...

January 18, 2007 -- Primary kidney-transplant recipients maintained on sirolimus ( Rapamune, Wyeth) and cyclosporine ( Neoral, Novartis) immunosuppression after a 5-day induction with antithymocyte ...

For patients with leukemias, certain types of anemias, or specific autoimmune disorders, hematopoietic stem cell transplantation is a life-saving procedure. This treatment involves suppressing a ...

After transplantation, patients are placed on immunosuppression to prevent acute and chronic rejection of the transplanted organ. The immunosuppressive agents used to treat acute rejection and nursing ...

Simultaneous Durvalumab and Platinum-Based Chemoradiotherapy in Unresectable Stage III Non–Small Cell Lung Cancer: The Phase III PACIFIC-2 Study To determine whether sirolimus (SIR) and cyclosporine ...